|
RAB11FIP5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.238630E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.362200E-04 |
| Normal-vs-Stage2 |
9.882100E-02 |
| Normal-vs-Stage3 |
8.832000E-04 |
| Normal-vs-Stage4 |
5.209200E-04 |
| Stage1-vs-Stage2 |
5.226800E-01 |
| Stage1-vs-Stage3 |
5.658200E-01 |
| Stage1-vs-Stage4 |
3.607600E-01 |
| Stage2-vs-Stage3 |
3.478200E-01 |
| Stage2-vs-Stage4 |
2.091400E-01 |
| Stage3-vs-Stage4 |
6.729000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.64789999999427E-05 |
| Normal-vs-AfricanAmerican |
8.757500E-03 |
| Normal-vs-Asian |
6.578200E-04 |
| Caucasian-vs-AfricanAmerican |
8.894000E-01 |
| Caucasian-vs-Asian |
3.482400E-01 |
| AfricanAmerican-vs-Asian |
6.173600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.30210000000164E-05 |
| Normal-vs-Female |
7.010700E-04 |
| Male-vs-Female |
1.579820E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.201770E-04 |
| Normal-vs-Age(41-60Yrs) |
1.764610E-03 |
| Normal-vs-Age(61-80Yrs) |
1.371660E-02 |
| Normal-vs-Age(81-100Yrs) |
1.339970E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.479600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.004800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.144000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.406400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.053200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.522000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.433600E-01 |
| Classical-VS-Follicular |
7.2430999975559E-08 |
| Classical-VS-Other |
6.163900E-02 |
| Classical-VS-Normal |
3.65440000038575E-07 |
| Tall-VS-Follicular |
1.881110E-03 |
| Tall-VS-Other |
6.200400E-02 |
| Tall-VS-Normal |
1.804270E-03 |
| Follicular-VS-Other |
9.748000E-01 |
| Follicular-VS-Normal |
6.969600E-01 |
| Other-VS-Normal |
7.911600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.332310E-02 |
| Normal-vs-N1 |
2.315800E-01 |
| N0-vs-N1 |
5.375800E-01 |
|
|
